Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism PAR-2 antagonists(Protease-activated receptor-2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | JP | 25 Aug 2009 |